title: Weighing the outcomes.
abstract: The emergent healthcare value era, its consequences, and what drug firms need to do about it.
authors.affiliation: The Bruckner Group, 27 Water Street, Suite 409, Wakefield, MA 01880, USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Russo
authors.forename: David
authors.initials: D
authors.lastname: Balekdjian
mesh_terms: D001688:Biological Products / Q000191:economics*; D001709:Biotechnology / Q000191:economics*; D007221:Industry / Q000191:economics*; D040541:Marketing / Q000191:economics*; D004364:Pharmaceutical Preparations / Q000191:economics*; D018570:Risk Assessment / Q000191:economics*; D014481:United States
chemical_list: D001688:Biological Products; D004364:Pharmaceutical Preparations